CORBF Income Statement - TTM - Global Cord Blood Corporation

Income Statement (TTM)

Global Cord Blood Corporation Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31
Revenue	1,201	1,157	1,160	1,194	1,222	1,248	1,243
Change (%)		-3.66	0.21	2.95	2.35	2.16	-0.41
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	183	176	179	183	185	187	183
Change (%)		-3.67	1.39	2.45	0.82	1.30	-2.10
% of Revenue	15.25	15.25	15.43	15.36	15.13	15.00	14.74

Gross Operating Profit	1,018	981	981	1,011	1,037	1,061	1,060
Change (%)		-3.66	-0.00	3.05	2.63	2.31	-0.11
% of Revenue	84.75	84.75	84.57	84.64	84.87	85.00	85.26

SG&A	424	413	412	418	423	423	429
Change (%)		-2.57	-0.19	1.48	1.11	0.09	1.33
% of Revenue	35.28	35.68	35.53	35.02	34.60	33.90	34.49

R&D	19	22	24	25	25	23	22
Change (%)		13.37	8.59	3.17	2.53	-8.51	-3.07
% of Revenue	1.61	1.89	2.05	2.05	2.06	1.84	1.79

OpEx	626	611	615	626	633	633	634
Change (%)		-2.40	0.58	1.82	1.08	0.10	0.16
% of Revenue	52.14	52.82	53.01	52.43	51.78	50.74	51.03

Operating Income	575	546	545	568	589	615	609
Change (%)		-5.03	-0.20	4.23	3.75	4.37	-0.99
% of Revenue	47.86	47.18	46.99	47.57	48.22	49.26	48.97

Interest Expense
Change (%)
% of Revenue

Net Income	506	478	508	512	506	524	501
Change (%)		-5.62	6.43	0.77	-1.11	3.48	-4.39
% of Revenue	42.12	41.26	43.83	42.90	41.45	41.98	40.30

Source: Capital IQ

Global Cord Blood Corporation - Income Statement (TTM)

Income Statement (TTM)